Severe prevalent vertebral fractures predict subsequent vertebral and nonvertebral fractures: a 3-year prospective study

in Annals of the Rheumatic Diseases (2012, June), 71(Suppl.3), 588

Perception, knowledge and use by general practitioners of Belgium of the FRAX tool

in Annals of the Rheumatic Diseases (2012, June), 71(Suppl.3), 716

Radiological and clinical profil of osteoarthritic patients undergoing of total joint replacement

in Annals of the Rheumatic Diseases (2012, June), 71(Suppl.3), 693

Trends in hip fracture incidence and in the prescription of anti-osteoporosis medications during same time period in Belgium (2000-2007)

in Arthritis Care & Research (2012), 64(5), 744-750

Health claims assessment in the field of joint and cartilage: a consensus viewpoint of the Group for the Respect of Ethics and Excellence in Science

in Current Medical Research & Opinion (2012), 28(4), 611-6

Abstract Introduction: In 2006, the European Parliament and Council issued a regulation (No. 1924/2006) for the nutrition and health claims made on foods, including food supplements. According to the ... [more ▼]

Abstract Introduction: In 2006, the European Parliament and Council issued a regulation (No. 1924/2006) for the nutrition and health claims made on foods, including food supplements. According to the regulation, the use of nutrition and health claims shall only be permitted if the substance in respect of which the claim is made has been shown to have a beneficial nutritional or physiological effect. In the field of joint and cartilage health, there is no clear scientific-based definition of the nature of such a beneficial nutritional or physiological effect. The objective of this paper is to scientifically define the possible content of health claims related to joint and cartilage health and to provide scientific guidelines for the design of clinical studies which need to be adopted to substantiate such health claims. Methods: Literature review up to September 2011 followed by a consensus expert discussion organized by the Group for the Respect of Ethics and Excellence in Science (GREES). Results: In line with the general principles of the PASSCLAIM and the Codex recommendations, the GREES identified four acceptable health claims related to joint and cartilage health based on the effects on discomfort, joint and cartilage structural integrity or risk factors for joint and cartilage diseases. The GREES considers that randomized controlled trials on a relevant outcome is the best design to assess health claims. Moreover, animal studies could also be of interest to substantiate some health claims, to assess the clinical relevance of endpoints used in human studies or to extrapolate data obtained in patients to the target (apparently) healthy population. Conclusion: According to the methodology and biomarkers used in the study and whether or not additional animal studies are provided to support the claim, various health claims can be acceptable in the field of joint and cartilage health. [less ▲]

Antidepressant use and fracture risk: a meta-analysis

Conference (2012, March 24)

Health claims for nutriceuticals products in the field of cartilage and joint

Conference (2012, March 23)

How to define responders in osteoarthritis?

Conference (2012, March 23)

A very high prevalence of vitamin D inadequacy combined with low dietary calcium intake is found in European postmenopausal women

in Osteoporosis International (2012, March), 23(Suppl. 2), 361

Effect of collagen hydrolysate in articular pain: A 6-month randomized, double-blind, placebo controlled study

in Osteoporosis International (2012, March), 23(Suppl. 2), 362-363